26 results on '"Haluska, Frank G."'
Search Results
2. Molecular Pathogenesis of Cutaneous Melanocytic Neoplasms.
3. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.
4. Melanoma in the Young: Differences and Similarities With Adult Melanoma.
5. Novel inhibitors in the treatment of metastatic melanoma.
6. Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).
7. PTEN signaling pathways in melanoma.
8. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.
9. Hypopigmentation Associated With an Adenovirus-Mediated gp100/MART-1–Transduced Dendritic Cell Vaccine for Metastatic Melanoma.
10. Low Prevalence of Germline CDKN2A and CDK4 Mutations in Patients With Early-Onset Melanoma.
11. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes.
12. Adjuvant High-Dose Interferon Alfa-2b in Patients with High-Risk Melanoma.
13. Outcome of Patients With Melanoma and Histologically Negative Sentinel Lymph Nodes.
14. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
15. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21.
16. ONCOGENE ACTIVATION BY CHROMOSOME TRANSLOCATION IN HUMAN MALIGNANCY.
17. Mutations of the CDKN2/p16 gene in Australian melanoma kindreds.
18. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8; 14) translocation separate c-myc and the IgH locus up to several hundred kb.
19. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining.
20. The t(8;14) breakpoint of the EW 36 undifferentiated lymphoma cell line lies 5' of MYC in a region prone to involvement in endemic Burkitt's lymphomas.
21. Molecular Mechanisms of Chromosome Translocation in Human B- and T-cell Neoplasiaa.
22. Lack of phospholipase A.
23. 4-Year Results from the Pivotal Phase 2 PACE Trial: Efficacy and Safety in Heavily Pretreated Leukemia Patients.
24. Screening strategies for cancer.
25. p380-8A 1.8 SaSs, a single copy clone 5′ of c-myc at 8q24 which recognizes an SstI polymorphism.
26. More clues to gene rearrangements.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.